CARDIOL THERAPEUTICS INC. (CRDL)
Cardiol Therapeutics Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association
Cardiol Therapeutics Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association
📈 **POSITIVE** • Medium confidence analysis (70%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business